phase readout
saveNCT04377555: Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab
COMPLETEDupdated 1d ago
community read0 votes
Sponsor: Genentech, Inc.. Phase: PHASE4. Conditions: Multiple Sclerosis, Relapsing
view source ↗
comments(0)
5-min edit window · permanent after that